This report came out the day before MSB result which turns this outcome on it's head... it's a new paradigm get used to it... we can't do everything double blind crossover it would not be ethical to withhold this treatment we know what the placebo rate is just give more people the drug and see how many survive
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-478
-
- There are more pages in this discussion • 370 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.028(2.44%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.10 | $1.748M | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 141980 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 7749 | 2 |
View Market Depth
| Last trade - 10.42am 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |